Register for EACPT Focus Meeting in Opatija, Croatia on How to Assess Medicines 6th - 9th October

There is still time to register for the next EACPT Focus Meeting which will be held from 6th to 9th October, 2016 in partnership with the Croatian Society for Clinical Pharmacology and Therapeutics.

The theme of the meeting is “How to Assess Medicines from Research to Clinical Practice”.

There is a bursary fund of 10,000 € to support abstract presenters.

See meeting programme

Key dates

Online Meeting Registration Deadline - September 30, 2016  

 

The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner.

The meeting will include a combination of scientific podium lectures, interactive workshops and guided poster sessions covering three main pillars important for the critical assessment of medicinal products - efficacy, effectiveness, and economics (3E assessment).

There will be a dedicated session for Young Pharmacologists during the meeting. There will be an EACPT Scientific Communication Award for the best presentation by a young scientist. 

Confirmed speakers and topics

JANNE TAPIO BACKMAN (Finland): Clinical drug-drug interaction studies: methods, pitfalls and interpretation

NADA BOŽINA (Croatia): The role of pharmacogenetics in individulized treatment choices

YLVA BOTTIGER (Sweden): National model for the introduction and follow-up of new, expensive drugs in Sweden

GONZALO CALVO (Spain): Accelerated approval paths. What they do mean and what they should not mean?

SIMON MAXWELL (UK): Safe introduction of new medicines into clinical practice

KEN PATERSON (UK): Rapid Health Technology Assessment of New Medicines - Lessons from 15 Years Experience in Scotland

WORKSHOP 2: EXCELLENCE IN CLINICAL RESEARCH - CLINICAL TRIAL DESIGN

IGOR FRANCETIĆ (Croatia): Effectiveness assessment: when pharmacokinetics makes a difference / macrolide and azalide examples

MATTHIAS SCHWAB (Germany): Pharmacogenomics and drug response: future challenges

EDUARDO SPINA (Italy): Efficacy of antidepressants: issues related to bias in clinical trials

TABASSOME SIMON (France): Key points for building succesful clinical trial

SINIŠA TOMIĆ (Croatia): The Role of the National Competent Authority (NCA) in the Assessment of Medicinal Products in the National Procedure

DONALD SINGER (UK): Personalised medicine approaches for identifying effective therapies

SLOBODAN VUKIČEVIĆ (Croatia): Current challenges and hurdles in new drug development

We will be guests in the Adriatic coastal town Opatija, Croatia. Opatija lies at the centre of the Kvarner Riviera with the longest tradition of providing quality conference venues in Croatia. Opatija’s very attractive geographic location, lush green scenery and a pleasant climate (45° 20’ north latitude) were some of the main reasons for its origins and the rapid development of its tourism from the end of the 19th century.  The venue – Grand Hotel 4 Opatijska Cvijeta –  is located in the very centre of Opatija and includes four buildings that were named after Opatija’s best-known flowers. The hotel has 223 rooms. The hotel also includes the large Tamaris congress centre, which has 7 multi-functional halls and the latest congress equipment.

Anyone from anywhere in the world with a professional interest in clinical pharmacology
and therapeutics can now join the EACPT as an Individual Associate member.
Membership benefits include:

• Access to videos of talks from EACPT Meetings

• Discounted registration fees for EACPT meetings

• Online access to the Official EACPT Journal - Clinical Therapeutics

• Access to the EACPT’s worldwide network of Individual Associate Members

• Active involvement in EACPT 

The EACPT was founded 24 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.

Update from Barcelona on the EACPT

The EACPT Executive Committee met in Barcelona from 27th - 28^th November

Sagrada Familia, Barcelona

to

plan for future activities including its next Focus Meeting to be held in Opatija in Croatia from 6th - 9th October 2016 and the 13th biennial Congress of the EACPT, to be held in Prague, Czech Republic in June 2017. 

The theme of the October 2016 EACPT Focus Meeting is “How to Assess Medicines from Research to Clinical Practice? Efficacy, Effectiveness, and Economic – 3E Assessment”. The main objectives of this Focus Meeting are to increase awareness, knowledge and use of critical assessment pillars for medicinal products in everyday clinical practice in order to improve healthcare outcomes in affordable manner. 

The Prague EACPT Congress in 2017 will provide an international scientific and educational

Members of the EACPT Executive Committee: Sagrada Familia

forum for discussion of clinical pharmacology and personalised pharmacotherapy. Themes will include the latest developments on effectiveness and safety of medicines, clinical pharmacology in clinical practice, innovative techniques, and advanced practices in topics such as drug discovery, drug development, new pharmacology and pharmacotherapy, safety in prescribing and updates on personalised medicines. 

There were updates on the progress of current and new working groups for Young Pharmacologists, Ethics, Regulatory issues and Education.

There were also reports on interaction with other professional organisations and societies, including the European Medicines Agency, IUPHAR (the International Union of Pharmacology) and EPHAR (the European Federation of Pharmacology Societies) and an update on interactions with Clinical Therapeutics, the Official Journal of EACPT.

The 2019 EACPT Congress will be held in Stockholm and the 2021 EACPT Congress in Athens. 

Click here to apply online for EACPT membership. 

Anyone from anywhere in the world with a professional interest in clinical pharmacology and/or therapeutics can now join the EACPT as an Individual Associate member.

Membership benefits include:

• Access to videos of talks from EACPT Meetings
• Discounted registration fees for EACPT meetings
• Online access to the Official EACPT Journal - Clinical Therapeutics
• Access to the EACPT’s worldwide network of Individual Associate Members
• Active involvement in EACPT 

The last EACPT Congress was held in June 2015 in Madrid where over 500 abstracts were presented as e-posters and 54 oral presentations. 

The EACPT was founded 23 years ago and now includes as members all national organisations for clinical pharmacology in Europe, as well as organisations from further afield internationally. The EACPT aims to provide educational and scientific support for the more than 4000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region, with its congresses attended by a global audience. The EACPT also advises policy makers on how the specialty can contribute to human health and wealth.